Mount Sinai Health System, Inc.
- SEC CIK
- 0001883135
No open-market purchases or sales filed in the past year.
Current role at each company
- WGS GeneDx Holdings Corp.10% Owneras of Nov 19, 2024
- RENXF Renalytix plc10% Owneras of Nov 5, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mount Sinai Health System, Inc. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
WGS GeneDx Holdings Corp.
10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2024 (view filing)8:00 PM ET | Nov 15-18 | 4 days | Mount Sinai Health System, Inc. and 1 other10% Owner | SSaleClass A Common Stock | −147.1K | $70.64 | −$10.4M | −5.1%2.72M after | 2 lots |
| Nov 4, 2024 (view filing)5:01 PM ET | Oct 31 | 4 days | Mount Sinai Health System, Inc. and 1 other10% Owner | SSaleClass A Common Stock | −865.8K | $75.00 | −$64.9M | −23.2%2.87M after | |
| Feb 2, 2023 (view filing)6:35 PM ET | Jan 31 | 2 days | Mount Sinai Health System, Inc. and 1 other10% Owner | PPurchaseClass A Common Stock | +28.6M | $0.35 | +$10.0M | +30.2%123.2M after | |
| May 5, 2022 (view filing)7:27 PM ET | Apr 29 | 6 daysLate | Mount Sinai Health System, Inc. and 1 other10% Owner | PPurchaseClass A Common Stock | +6.25M | $4.00 | +$25.0M | +7.1%94.6M after |